A 45-year-old with severe obesity and T2D has A1C 8.9% despite metformin and SGLT2 inhibitor. He is reluctant about injectables. Which oral option low...

Question

A 45-year-old with severe obesity and T2D has A1C 8.9% despite metformin and SGLT2 inhibitor. He is reluctant about injectables. Which oral option lowers A1C effectively with low hypoglycemia risk?

Accepted Answer

Repaglinide

Answer

Glyburide

Answer

Pioglitazone

Answer

Oral semaglutide

Answer

Acarbose

us-abfm MCQ (SBA): Type 2 Diabetes

A 45-year-old with severe obesity and T2D has A1C 8.9% despite metformin and SGLT2 inhibitor. He is reluctant about injectables. Which oral option lowers A1C effectively with low hypoglycemia risk?